(2024)
Exercise-changed gut mycobiome as a potential contributor to metabolic benefits in diabetes prevention: an integrative multi-omics study
Gut Microbes 16(1),
2416928.
Prof. Dr. Gianni Panagiotou
Microbiome Dynamics · Head +49 3641 532-1759 gianni.panagiotou@leibniz-hki.deCurriculum vitae
Main Research Areas
- Medical & Environmental Metagenomics: human, mice, marine, plants;
- Systems Biology: -omics integration, chemical-protein & protein-protein interaction networks;
- Synthetic Biology: genome-scale metabolic modelling, design of probiotics, discovery of postbiotics
Publications
(2024)
The gut microbiome, resistome, and mycobiome in preterm newborn infants and mouse pups: lack of lasting effects by antimicrobial therapy or probiotic prophylaxis.
Gut Pathog 16(1),
27.
(2024)
Beneficial microbiome and diet interplay in early-onset colorectal cancer.
EMBO Mol Med 17(1),
9-30.
(2023)
High-throughput profiling of Candida auris isolates reveals clade-specific metabolic differences.
Microbiol Spectr 11(3),
e0049823.
(Review)
(2023)
Human TH17 cells engage gasdermin E pores to release IL-1α on NLRP3 inflammasome activation.
Nat Immunol 24(2),
295-308.
(2023)
Identification of robust and generalizable biomarkers for microbiome-based stratification in lifestyle interventions.
Microbiome 11(1),
178.
(2023)
Gut ecological networks reveal associations between bacteria, exercise and clinical profile in non-alcoholic fatty liver disease patients.
mSystems 8(5),
e0022423.
(2023)
Pathogen-specific innate immune response patterns are distinctly affected by genetic diversity.
Nat Commun 14(1),
3239.
(2023)
Disruption of the A. fumigatus RNA interference machinery alters the conidial transcriptome.
RNA 29(7),
1033-1050.
(2023)
Impaired flux of bile acids from the liver to the gut reveals microbiome-immune interactions associated with liver damage.
NPJ Biofilms and microbiomes 9(1),
35.
